Back
Top 7%
11.8%
Top 0.1%
9.0%
Top 66%
7.8%
Top 3%
7.8%
Top 1.0%
6.4%
Top 3%
6.0%
Top 6%
5.6%
Top 0.7%
3.9%
Top 67%
3.9%
Top 42%
3.1%
Top 2%
3.1%
Top 2%
2.8%
Top 0.6%
1.9%
Top 5%
1.9%
Top 3%
1.9%
Top 4%
1.2%
Top 11%
1.0%
Top 23%
0.7%
Top 18%
0.7%
Top 35%
0.7%
Top 7%
0.7%
Top 3%
0.7%
Top 17%
0.5%
When Survival Improves But Quality of Life Does Not: A Model-Based Meta-Analysis of Immune Checkpoint Inhibitors
2026-03-05
oncology
Title + abstract only
View on medRxiv
Show abstract
BackgroundIn immune checkpoint inhibitor (ICI) trials, overall survival (OS) benefits are well established, yet improvements in quality of life (QoL) are often inconsistent or absent in conventional analyses. This apparent discordance raises important questions: are QoL outcomes truly unrelated to survival, and how can QoL results be better utilized and interpreted? MethodsA model-based meta-analysis (MBMA) of longitudinal EORTC QLQ-C30 global health status/quality of life data from randomized ...
Predicted journal destinations
1
Nature Communications
483 training papers
2
Clinical Cancer Research
22 training papers
3
PLOS ONE
1737 training papers
4
Cancers
57 training papers
5
JAMA Network Open
125 training papers
6
Frontiers in Oncology
34 training papers
7
eLife
262 training papers
8
BMC Cancer
21 training papers
9
Scientific Reports
701 training papers
10
BMJ Open
553 training papers
11
Cancer Medicine
17 training papers
12
British Journal of Cancer
22 training papers
13
Journal of Clinical Epidemiology
29 training papers
14
Proceedings of the National Academy of Sciences
100 training papers
15
iScience
74 training papers
16
Journal of Clinical Investigation
50 training papers
17
Frontiers in Immunology
140 training papers
18
PLOS Medicine
95 training papers
19
Nature Medicine
88 training papers
20
BMC Medicine
155 training papers
21
Communications Medicine
63 training papers
22
Cell Reports
25 training papers
23
PLOS Computational Biology
141 training papers